EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Trends and Regional Differences for Fertility Preservation Procedures in Women With Breast Cancer

Volkan Turan, Giuliano Bedoschi, Dong-Yun Lee, Caio Parente Barbosa, Renato de Oliveira, Koray Gorkem Sacinti, Murat Sonmezer, Matteo Lambertini, Claudia Massarotti, Amelia Schaub, Erica Wang, Sonia Gayete-Lafuente und 4 weitere

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2024.09.011 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Volkan Turan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Istanbul Health and Technology University School of Medicine, Istanbul, Turkey; Innovation Institute for Fer…. Hauptthemen laut MEDLINE: Fertility Preservation, Breast Neoplasms, Cryopreservation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Breast cancer is the most common malignancy in women of reproductive age and chemotherapy protocols impair fertility, frequently necessitating fertility preservation (FP) referral. Embryo, oocyte, or ovarian tissue cryopreservation are established FP modalities in women with breast cancer but there are few data on their uptake over time. In this study our aim was to determine the regional time trends and utility differences for fertility preservation methods of reproductive tissue cryopreservation. METHODS: This multicenter study included 1623 women diagnosed with breast cancer from 7 tertiary centers in 6 countries (Brazil, Italy, Scotland, South Korea, Turkey, USA). Participant centers provided the details of FP cryopreservation approaches broken down annually from 2012 to 2021. Women with newly diagnosed breast cancer, aged 18-45 years who were referred for FP at participating centers and had normal ovarian function at the time were included. RESULTS: We found a mean increase of 7% per year (P = .002, adjusting for centers) in the number of women referred for FP. Of those who were referred (n = 1623), a mean 38.7% underwent FP (n = 629), with a range of 12% in South Korea) to 95% in Brazil. The number of women undergoing ovarian stimulation for FP continually increased until 2021, with oocyte cryopreservation being the most common procedure throughout the study period (P = .014 for time trend). The proportion of random start ovarian stimulation cycles increased each year from 58.3% in 2012 to 86.8% in 2021, (P = .005 for time trend, and P = .04 for 2012 vs. 2021). CONCLUSIONS: The utility of FP has steadily increased for young women with breast cancer over the last decade, although regional differences significantly influence FP practices. The findings of our study could have value for policy making in FP care for young women with breast cancer at the local, regional, or global level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationBreast NeoplasmsCryopreservationHumansFemaleAdultMiddle AgedYoung AdultAdolescentOvulation InductionOocytes

Stichwörter der Autor:innen

CryopreservationEmbryoLetrozoleOocyteOvarian stimulation

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Istanbul Health and Technology University School of Medicine, Istanbul, Turkey; Innovation Institute for Fertility Preservation, Yorkvillle, NY and New Heaven, CT.
  • Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
  • Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Faculdade de Medicina do ABC, Santo Andre, Brazil.
  • Department of Obstetrics and Gynecology, Center of Human Reproduction and Infertility Ankara University, Ankara, Turkey.
  • Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Mar…

Förderung

  • NICHD NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Cancer Institute
  • National Institute of Child Health and Human Development

Zitieren

APA

Turan, V., Bedoschi, G., Lee, D. Y., Barbosa, C. P., de Oliveira, R., Sacinti, K. G., Sonmezer, M., Lambertini, M., Massarotti, C., Schaub, A., Wang, E., Gayete-Lafuente, S., Dunlop, C., Anderson, R. A., Bang, H., & Oktay, K. H. (2025). Trends and Regional Differences for Fertility Preservation Procedures in Women With Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.09.011

Vancouver

Turan V, Bedoschi G, Lee DY, Barbosa CP, de Oliveira R, Sacinti KG, et al. Trends and Regional Differences for Fertility Preservation Procedures in Women With Breast Cancer. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2024.09.011

BibTeX
@article{Turan2025,
  author = {Turan, Volkan and Bedoschi, Giuliano and Lee, Dong-Yun and Barbosa, Caio Parente and de Oliveira, Renato and Sacinti, Koray Gorkem and Sonmezer, Murat and Lambertini, Matteo and Massarotti, Claudia and Schaub, Amelia and Wang, Erica and Gayete-Lafuente, Sonia and Dunlop, Cheryl and Anderson, Richard A and Bang, Heejung and Oktay, Kutluk H},
  title = {Trends and Regional Differences for Fertility Preservation Procedures in Women With Breast Cancer},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2024.09.011}
}
Kostenlos starten →